Epidermodysplasia Verruciformis

Southern Medical Journal

Volumn 96, Issue 6, 2003, Pages 613-615

  Lane, Joshua E ^a   Bowman, Paul H ^b   Cohen, David J ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b NONE

Author keywords

Epidermodysplasia verruciformis; Human papillomavirus; Skin cancer

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CELLULAR IMMUNITY; CLINICAL FEATURE; DISEASE ASSOCIATION; EPIDERMODYSPLASIA VERRUCIFORMIS; HUMAN; MALE; SKIN CARCINOMA; WART VIRUS; MIDDLE AGED; PATHOLOGY; SKIN TUMOR;

EPIDERMODYSPLASIA VERRUCIFORMIS; HUMANS; MALE; MIDDLE AGED; SKIN NEOPLASMS;

EID: 0041883429     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SMJ.0000054544.47233.7C     Document Type: Article

References (14)

1. Lewandowsky F, Lutz W. Ein Fall einer bisher nicht beschriebenen Hauterkrankung (Epidermodysplasia verruciformis). Arch Dermatol Syphilol 1922;141:193-203.
2. Jacyk WK, deVilliers EM. Epidermodysplasia verruciformis in Africans. Int J Dermatol 1993;32:806-810.
3. Jablonska S, Majewski S. Epidermodysplasia verruciformis: Immunological and clinical aspects. Curr Top Microbiol Immunol 1994;186:157-175.
4. Lutzner MA. Epidermodysplasia verruciformis: An autosomal recessive disease characterized by viral warts and skin cancer. Bull Cancer 1978;65:169-182.
5. Harris AJ, Purdie K, Leigh IM, Proby C, Burge S. A novel human papillomavirus identified in epidermodysplasia verruciformis. Br J Dermatol 1997;136:587-591.
6. Majewski S, Skopinska-Rozewska E, Jablonska S, Wasik M, Misiewicz J, Orth G. Partial defects of cell-mediated immunity in patients with epidermodysplasia verruciformis. J Am Acad Dermatol 1986;15:966-973.
7. Cooper KD, Androphy EJ, Lowy DR, Katz SI. Antigen presentation and T-cell activation in epidermodysplasia verruciformis. J Invest Dermatol 1990;94:769-776.
8. Haftek M, Jablonska S, Szmanczyk J, Jarzabek-Chorzelska M. Langerhans cells in epidermodysplasia verruciformis. Dermatologica 1987;174:173-179.
9. Yutsudo M, Hakura A. Human papillomavirus type 17 transcripts expressed in skin carcinoma tissue of a patient with epidermodysplasia verruciformis. Int J Cancer 1987;39:586-589.
10. Deau MC, Favre M, Orth G. Genetic heterogeneity among human papillomaviruses (HPV) associated with epidermodysplasia verruciformis: Evidence for multiple allelic forms of HPV5 and HPV8 E6 genes. Virology 1991;184:492-503.
11. Astori G, Lavergne D, Benton C, Hockmayr B, Egawa K, Garbe C, et al. Human papillomaviruses are commonly found in normal skin of immunocompetent hosts. J Invest Dermatol 1998;110:752-755.
12. Steger G, Olsewsky M, Stockfleth E, Pfister H. Prevalence of antibodies to human papilloma virus type in the human sera. J Virol 1990;64:4399-4406.
13. Androphy EJ, Dvoretsky I, Lowy DR. X-linked inheritance of epidermodysplasia verruciformis: Genetic and virologic studies of a kindred. Arch Dermatol 1985;121:864-868.
14. Karrer S, Szeimies RM, Abels C, Wlotzke U, Stolz W, Landthaler M. Epidermodysplasia verruciformis treated using topical 5-aminoaevulinic acid photodynamic therapy. Br J Dermatol 1999;140:935-938.